You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Necrobiosis Lipoidica

Showing 1 - 20 of 20
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Necrobiosis Lipoidica Trial in Philadelphia, Pittsburgh (PCS499)

Completed
Has Results
  • Necrobiosis Lipoidica
  • Philadelphia, Pennsylvania
  • +1 more
Sep 1, 2022

Necrobiosis Lipoidica Trial in United States (PCS499, )

Recruiting
  • Necrobiosis Lipoidica
  • Scottsdale, Arizona
  • +6 more
Nov 1, 2022

Necrobiosis Lipoidica Trial in Scottsdale (Ruxolitinib)

Completed
  • Necrobiosis Lipoidica
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Mar 17, 2022

Necrobiosis Lipoidica Diabeticorum Trial in Boston (Secukinumab)

Terminated
  • Necrobiosis Lipoidica Diabeticorum
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Feb 4, 2022

Type 1 Diabetes, Lipoatrophy Trial (Apidra, current insulin)

Completed
  • Type 1 Diabetes
  • Lipoatrophy
  • (no location specified)
Oct 18, 2019

Type 2 Diabetes, Chronic Kidney Diseases Trial in Worldwide (Sotagliflozin (SAR439954), Placebo)

Terminated
Has Results
  • Heart Failure
  • +2 more
  • Birmingham, Alabama
  • +753 more
Sep 30, 2022

CKD Anemia Trial in Worldwide (Roxadustat, Placebo)

Completed
Has Results
  • CKD Anemia
  • Huntsville, Alabama
  • +144 more
Sep 1, 2021

Diabetic Kidney Disease Trial in Worldwide (Finerenone (BAY94-8862), Placebo)

Completed
Has Results
  • Diabetic Kidney Disease
  • Finerenone (BAY94-8862)
  • Placebo
  • Birmingham, Alabama
  • +974 more
Apr 13, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome Trial in Italy, United Kingdom, United States

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • +3 more
  • Boston, Massachusetts
  • +11 more
Nov 23, 2022

Diabetes, Type 2 Trial in Canada, United States (Insulin glargine, 300 U/ml, Insulin glargine, 100 U/ml, Insulin detemir)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Insulin glargine, 300 U/ml
  • +3 more
  • Birmingham, Alabama
  • +426 more
Aug 28, 2019

Anemia Trial in Worldwide (Roxadustat, Placebo)

Completed
Has Results
  • Anemia
  • Birmingham, Alabama
  • +359 more
Nov 27, 2019

Diabetes, Type 2 Trial in Worldwide (Ticagrelor 60 mg, Ticagrelor )

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Ticagrelor 60 mg
  • Ticagrelor placebo
  • Alexander City, Alabama
  • +1241 more
Mar 4, 2020

Coronary Artery Disease Trial in Ferrara, London (Ivabradine, Placebo)

Completed
Has Results
  • Coronary Artery Disease
  • Ferrara, Italy
  • +1 more
Mar 2, 2020

Heart Failure, Coronary Artery Disease Trial in Worldwide (Rivaroxaban, Placebo, Standard of care for heart failure and coronary

Completed
Has Results
  • Heart Failure
  • Coronary Artery Disease
  • Alexander City, Alabama
  • +577 more
Apr 18, 2019

Diabetes, Type 2 Trial in Worldwide (Placebo, Linagliptin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Huntsville, Alabama
  • +648 more
Mar 21, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Alabaster, Alabama
  • +427 more
Jul 3, 2019

Diabetes, Type 2, Cardiovascular Diseases, Risk Factors Trial in Worldwide (Placebo, Canagliflozin (JNJ-28431754) 100 mg,

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • +2 more
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +312 more
Nov 5, 2018

Peripheral Artery Disease Trial in Worldwide (Ticagrelor, Clopidogrel)

Completed
Has Results
  • Peripheral Artery Disease
  • Alexander City, Alabama
  • +777 more
Sep 29, 2017

Venous Thrombosis, Pulmonary Embolism Trial in Worldwide (Apixaban, Enoxaparin)

Completed
Has Results
  • Venous Thrombosis
  • Pulmonary Embolism
  • Birmingham, Alabama
  • +296 more
Dec 7, 2015

Obesity Trial in North Chicago (Sibutramine HCl, Placebo)

Completed
Has Results
  • Obesity
  • Sibutramine hydrochloride
  • Placebo
  • North Chicago, Illinois
    Global Medical Services
May 6, 2010